,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Ear infection,1,16689468
1,22.1,Tympanic membrane perforation,1,16689468
2,22.1,Ear pain,3,16689468
3,22.1,Bronchitis,6,16689468
4,22.1,Hypoacusis,2,16689468
5,22.1,Otorrhoea,6,16689468
0,22.0,Neutropenia,2,16689471
0,22.1,Alopecia,2,16689492
1,22.1,Emotional distress,6,16689492
2,22.1,Psychological trauma,6,16689492
3,22.1,Anxiety,6,16689492
4,22.1,Impaired quality of life,6,16689492
5,22.1,Pain,6,16689492
0,22.0,Hyperhidrosis,6,16689504
1,22.0,Rash,6,16689504
2,22.0,Visual impairment,6,16689504
3,22.0,Loss of consciousness,6,16689504
4,22.0,Blood pressure decreased,6,16689504
5,22.0,Pyrexia,6,16689504
0,22.1,Alopecia,2,16689507
1,22.1,Anxiety,3,16689507
2,22.1,Psychological trauma,6,16689507
0,22.1,Emotional distress,6,16689516
1,22.1,Impaired quality of life,6,16689516
2,22.1,Pain,6,16689516
3,22.1,Alopecia,3,16689516
4,22.1,Psychological trauma,6,16689516
5,22.1,Anxiety,6,16689516
0,22.0,Malignant neoplasm progression,6,16689646
1,22.0,Weight decreased,6,16689646
2,22.0,Diarrhoea,6,16689646
3,22.0,Cardiomegaly,6,16689646
4,22.0,Blood creatine phosphokinase increased,2,16689646
5,22.0,Anaemia,6,16689646
6,22.0,Fall,6,16689646
7,22.0,Liver disorder,2,16689646
8,22.0,Decreased appetite,6,16689646
9,22.0,Pyrexia,6,16689646
10,22.0,Rhabdomyolysis,6,16689646
11,22.0,Metastases to pelvis,6,16689646
12,22.0,Pathological fracture,6,16689646
13,22.0,Cardiac dysfunction,1,16689646
14,22.0,Urinary tract infection,6,16689646
0,22.1,Pancreatitis,4,16689660
1,22.1,Enteritis,1,16689660
0,22.0,Myocardial infarction,1,16689723
0,22.0,Pyrexia,6,16689740
1,22.0,Nasopharyngitis,6,16689740
2,22.0,Immune system disorder,6,16689740
3,22.0,Cardiac disorder,6,16689740
0,22.1,Pemphigoid,2,16689751
0,22.0,Hyperaesthesia,3,16689762
1,22.0,Loss of personal independence in daily activities,3,16689762
2,22.0,Pain in extremity,3,16689762
3,22.0,Gait inability,3,16689762
4,22.0,Off label use,,16689762
0,22.0,Metastases to lung,6,16689777
1,22.0,Malignant neoplasm progression,6,16689777
2,22.0,Metastases to bone,6,16689777
3,22.0,Metastases to ovary,6,16689777
4,22.0,Metastases to pelvis,6,16689777
5,22.0,Hormone level abnormal,3,16689777
0,22.0,Hypertransaminasaemia,2,16689788
0,22.0,Product use in unapproved indication,6,16689875
1,22.0,Brain oedema,6,16689875
2,22.0,Metastases to spine,6,16689875
3,22.0,Malignant neoplasm progression,6,16689875
4,22.0,Altered state of consciousness,6,16689875
5,22.0,Metastases to central nervous system,6,16689875
0,22.0,Thyroid disorder,2,16689889
1,22.0,Adrenocorticotropic hormone deficiency,2,16689889
0,22.0,Hepatitis,2,16689922
1,22.0,Malignant neoplasm progression,6,16689922
2,22.0,Acute kidney injury,2,16689922
3,22.0,Triple negative breast cancer,6,16689922
4,22.0,Leukopenia,2,16689922
5,22.0,Altered state of consciousness,2,16689922
6,22.0,Product use in unapproved indication,6,16689922
0,22.1,Blood glucose increased,2,16689928
1,22.1,Dysgeusia,6,16689928
2,22.1,Abdominal pain upper,6,16689928
3,22.1,Dry mouth,6,16689928
4,22.1,Nausea,6,16689928
5,22.1,Blood magnesium decreased,6,16689928
6,22.1,Stomatitis,6,16689928
0,22.0,Constipation,1,16689969
1,22.0,Toothache,1,16689969
2,22.0,Skin hypertrophy,1,16689969
3,22.0,Renal failure,1,16689969
4,22.0,Oedema peripheral,1,16689969
5,22.0,Swelling face,1,16689969
6,22.0,Dry skin,1,16689969
7,22.0,Stomatitis,1,16689969
8,22.0,Back pain,1,16689969
9,22.0,Polycythaemia,1,16689969
10,22.0,Blister,1,16689969
11,22.0,Urinary tract infection,1,16689969
12,22.0,Neutropenia,1,16689969
13,22.0,Nausea,1,16689969
14,22.0,Diarrhoea,1,16689969
15,22.0,Thrombocytopenia,1,16689969
16,22.0,Pyrexia,1,16689969
17,22.0,Hypertension,1,16689969
18,22.0,Skin irritation,1,16689969
19,22.0,Yellow skin,1,16689969
20,22.0,Pain in extremity,1,16689969
21,22.0,Anaemia,1,16689969
22,22.0,Eyelid oedema,1,16689969
23,22.0,Flatulence,1,16689969
24,22.0,Leukopenia,1,16689969
25,22.0,Hypothyroidism,1,16689969
26,22.0,Abdominal pain upper,1,16689969
27,22.0,Feeling hot,1,16689969
28,22.0,Eructation,1,16689969
0,22.0,Bone marrow failure,1,16689989
0,22.0,Interstitial lung disease,2,16690006
0,22.1,Skin ulcer,2,16690036
0,22.0,Malignant neoplasm progression,5,16690212
0,22.0,Root canal infection,3,16690259
1,22.0,Oesophageal pain,3,16690259
0,22.0,Neuralgia,6,16690288
1,22.0,Product use in unapproved indication,6,16690288
0,22.0,Pain,2,16690332
1,22.0,Metastases to bone,6,16690332
2,22.0,Metastases to spine,6,16690332
3,22.0,Metastases to liver,2,16690332
0,22.0,Renal impairment,6,16690344
1,22.0,Bone marrow failure,6,16690344
0,22.0,Hypokalaemia,1,16690350
0,22.1,Immunosuppression,6,16690390
0,22.0,Rash,3,16690397
0,22.0,Death,5,16690404
0,22.0,Death,5,16690443
0,22.0,Malignant neoplasm progression,5,16690483
0,22.0,Cardiotoxicity,6,16690525
1,22.0,Ejection fraction decreased,6,16690525
0,22.0,Ejection fraction decreased,6,16690526
1,22.0,Cardiotoxicity,6,16690526
0,22.0,Cardiotoxicity,6,16690527
1,22.0,Ejection fraction decreased,6,16690527
0,22.0,Ejection fraction decreased,6,16690528
1,22.0,Cardiotoxicity,6,16690528
0,22.0,Ejection fraction decreased,6,16690530
1,22.0,Cardiotoxicity,6,16690530
0,22.1,Pneumonia,3,16690536
1,22.1,Syncope,6,16690536
2,22.1,Diarrhoea,6,16690536
3,22.1,Weight decreased,6,16690536
0,22.0,Hyperpyrexia,5,16690551
1,22.0,Lung infection,3,16690551
0,22.0,Face oedema,6,16690582
0,22.0,Death,5,16690586
0,22.0,Optic neuritis,2,16690588
0,22.1,Choking,6,16690602
1,22.1,Dementia,6,16690602
2,22.1,Fall,6,16690602
3,22.1,Fatigue,3,16690602
4,22.1,Death,5,16690602
5,22.1,Hip fracture,6,16690602
6,22.1,Product use complaint,3,16690602
0,22.0,Angina pectoris,6,16690619
0,22.1,Interstitial lung disease,5,16690629
0,22.0,Haematemesis,1,16690677
1,22.0,Neutropenia,1,16690677
2,22.0,Hypernatraemia,1,16690677
3,22.0,Nausea,3,16690677
4,22.0,Malaise,1,16690677
5,22.0,Candida infection,1,16690677
6,22.0,Decreased appetite,3,16690677
7,22.0,Onychalgia,3,16690677
8,22.0,Fatigue,3,16690677
9,22.0,Pain in jaw,1,16690677
10,22.0,Alopecia,1,16690677
0,22.0,Paraparesis,6,16690688
0,22.0,Platelet count decreased,2,16690705
0,22.0,Death,5,16690743
0,22.0,Platelet count decreased,6,16690766
0,22.0,Product availability issue,6,16690802
1,22.0,Product dose omission,6,16690802
2,22.0,No adverse event,6,16690802
0,22.1,Facial paralysis,2,16690819
0,22.0,Pulmonary embolism,6,16690899
1,22.0,Infusion related reaction,6,16690899
0,22.0,Pyrexia,2,16690967
1,22.0,Cystitis,2,16690967
2,22.0,Acute hepatic failure,2,16690967
0,22.0,Disease recurrence,6,16691100
0,22.0,Disease recurrence,6,16691101
0,22.0,Disease recurrence,6,16691102
0,22.0,Disease recurrence,6,16691103
0,22.0,Underdose,6,16691131
1,22.0,Treatment noncompliance,6,16691131
2,22.0,Cerebrovascular accident,6,16691131
0,22.0,Pneumothorax,6,16691136
0,22.0,Deep vein thrombosis,1,16691145
1,22.0,Pulmonary embolism,1,16691145
2,22.0,Tumour thrombosis,1,16691145
0,22.0,Febrile neutropenia,6,16691271
0,22.0,Disturbance in attention,1,16691274
0,22.0,Off label use,6,16691277
1,22.0,Amenorrhoea,2,16691277
2,22.0,Paraesthesia,2,16691277
0,22.0,Haematotoxicity,1,16691301
0,22.1,Thrombocytopenia,1,16691318
0,22.0,Cardiotoxicity,6,16691336
1,22.0,Ejection fraction decreased,6,16691336
0,22.0,Septic shock,5,16691370
1,22.0,Neutrophil count decreased,1,16691370
2,22.0,Colitis,5,16691370
0,22.0,Death,5,16691408
1,22.0,Arthralgia,6,16691408
2,22.0,Pneumonia,6,16691408
3,22.0,Sepsis,6,16691408
4,22.0,Malaise,6,16691408
5,22.0,Alopecia,6,16691408
6,22.0,Lung infection,6,16691408
7,22.0,Joint swelling,6,16691408
8,22.0,Condition aggravated,6,16691408
0,22.1,Meningitis,2,16691410
0,22.0,Nausea,2,16691427
1,22.0,Platelet count decreased,2,16691427
2,22.0,Diarrhoea,2,16691427
3,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16691427
4,22.0,Haemoglobin decreased,2,16691427
5,22.0,Vomiting,2,16691427
6,22.0,Urethral disorder,2,16691427
7,22.0,Skin reaction,2,16691427
8,22.0,White blood cell count decreased,2,16691427
0,22.1,Interstitial lung disease,2,16691433
1,22.1,Pneumonia,6,16691433
0,22.0,Diarrhoea,6,16691437
1,22.0,Vomiting,6,16691437
0,22.0,Tumour marker increased,6,16691451
1,22.0,Stomatitis,6,16691451
0,22.0,Rash generalised,6,16691463
0,22.0,Bone marrow failure,6,16691466
1,22.0,Gastrointestinal disorder,6,16691466
2,22.0,Alopecia,6,16691466
3,22.0,Alanine aminotransferase increased,6,16691466
0,22.0,Dry mouth,2,16691482
1,22.0,Neutropenia,2,16691482
2,22.0,Mucosal inflammation,2,16691482
0,22.0,Delirium,1,16691495
0,22.0,Malignant neoplasm progression,6,16691529
0,22.0,Wernicke^s encephalopathy,6,16691548
1,22.0,Vitamin B1 deficiency,6,16691548
0,22.1,Fatigue,6,16691551
0,22.0,Alopecia,6,16691561
1,22.0,Bone marrow failure,6,16691561
2,22.0,Gastrointestinal disorder,6,16691561
3,22.0,Renal impairment,6,16691561
0,22.1,Febrile neutropenia,2,16691562
1,22.1,Pneumonia,2,16691562
0,22.0,Off label use,6,16691618
1,22.0,Intentional product use issue,6,16691618
2,22.0,Renal tubular disorder,6,16691618
3,22.0,Neuropathy peripheral,6,16691618
0,22.0,Disseminated Bacillus Calmette-Guerin infection,3,16691628
0,22.0,Stomatitis,1,16691678
0,22.1,Penile haemorrhage,1,16691769
1,22.1,Cyst,1,16691769
0,22.0,Oedema peripheral,1,16691776
0,22.0,Fall,6,16691785
1,22.0,Death,5,16691785
2,22.0,Blindness,6,16691785
3,22.0,General physical health deterioration,6,16691785
0,22.0,Neutropenia,6,16691790
1,22.0,Febrile neutropenia,6,16691790
2,22.0,Product use in unapproved indication,6,16691790
3,22.0,Off label use,6,16691790
0,22.0,Embolism,6,16691801
1,22.0,Drug hypersensitivity,2,16691801
2,22.0,Pruritus,2,16691801
3,22.0,Asthma,6,16691801
4,22.0,Wound infection,6,16691801
5,22.0,Dyspnoea,6,16691801
6,22.0,Enterocutaneous fistula,6,16691801
7,22.0,Neoplasm progression,6,16691801
0,22.0,Bedridden,3,16691809
1,22.0,Pain in extremity,3,16691809
0,22.0,Sciatica,2,16691810
1,22.0,Bone marrow oedema,2,16691810
2,22.0,Osteoporosis,6,16691810
3,22.0,Lumbar vertebral fracture,1,16691810
0,22.0,Hyperbilirubinaemia,2,16691837
1,22.0,Flatulence,2,16691837
2,22.0,Thrombocytopenia,2,16691837
0,22.0,Hypotension,1,16691869
1,22.0,Laryngeal oedema,1,16691869
0,22.0,Thrombocytopenia,3,16691884
1,22.0,Leukopenia,3,16691884
2,22.0,Anaemia,3,16691884
0,22.0,Cerebral haemorrhage,1,16691917
0,22.0,Eyelid oedema,1,16691920
1,22.0,Hypotension,1,16691920
2,22.0,Rash macular,1,16691920
3,22.0,Swelling,1,16691920
0,22.1,Nausea,1,16691923
1,22.1,Off label use,6,16691923
2,22.1,Vomiting,1,16691923
3,22.1,Asthenia,1,16691923
4,22.1,Decreased appetite,1,16691923
5,22.1,Constipation,1,16691923
6,22.1,Throat tightness,1,16691923
0,22.1,Drug interaction,2,16691928
1,22.1,Rash,1,16691928
0,22.0,Pyrexia,2,16691962
0,22.0,Blindness,1,16691983
1,22.0,Ocular hyperaemia,1,16691983
0,22.0,Gastrointestinal haemorrhage,6,16692021
1,22.0,Cerebral infarction,6,16692021
0,22.0,Lung disorder,5,16692047
1,22.0,Intentional product use issue,6,16692047
0,22.1,Oedema,6,16692053
1,22.1,Malignant neoplasm progression,6,16692053
0,22.0,Radiation pneumonitis,2,16692054
0,22.0,Neuropathy peripheral,3,16692061
0,22.0,Fatigue,6,16692108
1,22.0,Nausea,6,16692108
2,22.0,Infection,6,16692108
3,22.0,Mental status changes,6,16692108
4,22.0,Stomatitis,6,16692108
5,22.0,Blood bilirubin increased,6,16692108
6,22.0,Ascites,6,16692108
7,22.0,Abdominal pain,6,16692108
8,22.0,Dyspnoea,6,16692108
9,22.0,Peritonitis,6,16692108
10,22.0,Blood alkaline phosphatase increased,6,16692108
11,22.0,Thrombocytopenia,6,16692108
12,22.0,Pyrexia,6,16692108
13,22.0,Upper gastrointestinal haemorrhage,6,16692108
14,22.0,Embolism,6,16692108
15,22.0,Cholecystitis,6,16692108
16,22.0,Hypokalaemia,6,16692108
17,22.0,Cholangitis,6,16692108
18,22.0,Pneumonitis,6,16692108
19,22.0,Delirium,6,16692108
20,22.0,Urinary retention,6,16692108
21,22.0,Anaemia,6,16692108
22,22.0,Neutropenia,6,16692108
0,22.1,Hepatic function abnormal,1,16692110
1,22.1,Radiation pneumonitis,2,16692110
2,22.1,Hyperglycaemia,3,16692110
0,22.0,Insomnia,6,16692111
1,22.0,Interstitial lung disease,2,16692111
2,22.0,Herpes zoster,2,16692111
0,22.0,Lactic acidosis,3,16692118
1,22.0,Hyperlactacidaemia,3,16692118
2,22.0,Sepsis,1,16692118
0,22.0,Arthralgia,6,16692129
1,22.0,Fatigue,6,16692129
2,22.0,Pain,6,16692129
3,22.0,Pain in extremity,6,16692129
4,22.0,Paraesthesia,6,16692129
5,22.0,Polyneuropathy,6,16692129
0,22.0,Hypersensitivity pneumonitis,1,16692157
1,22.0,Lung infiltration,1,16692157
0,22.0,Metastases to lung,6,16692180
0,22.0,Malignant neoplasm progression,6,16692181
1,22.0,Metastases to lung,6,16692181
2,22.0,HER-2 positive breast cancer,6,16692181
0,22.0,Acute respiratory failure,6,16692193
1,22.0,Sepsis,6,16692193
2,22.0,Neutropenia,6,16692193
0,22.0,Blood alkaline phosphatase increased,6,16692336
1,22.0,Febrile neutropenia,6,16692336
2,22.0,Hypokalaemia,6,16692336
0,22.0,Arthritis,3,16692389
0,22.0,Constipation,1,16692460
1,22.0,Impaired driving ability,6,16692460
2,22.0,Diarrhoea,1,16692460
3,22.0,Feeling abnormal,6,16692460
4,22.0,Gastric disorder,6,16692460
0,22.1,Stomatitis,1,16692467
1,22.1,White blood cell count decreased,6,16692467
2,22.1,Red blood cell count decreased,6,16692467
3,22.1,Diarrhoea,3,16692467
4,22.1,Chills,3,16692467
5,22.1,Constipation,3,16692467
0,22.0,Lactic acidosis,3,16692490
1,22.0,Hyperlactacidaemia,3,16692490
2,22.0,Sepsis,1,16692490
0,22.1,Platelet count decreased,3,16692495
1,22.1,Fatigue,3,16692495
2,22.1,Platelet count decreased,1,16692495
3,22.1,Febrile neutropenia,1,16692495
4,22.1,Lymphocyte count decreased,1,16692495
5,22.1,Anaemia,1,16692495
0,22.0,Skin toxicity,6,16692559
1,22.0,Pulmonary toxicity,6,16692559
2,22.0,Anaemia,1,16692559
3,22.0,Thrombocytopenia,1,16692559
4,22.0,Nausea,6,16692559
5,22.0,Vomiting,6,16692559
6,22.0,Cardiotoxicity,6,16692559
7,22.0,Neutropenia,1,16692559
8,22.0,Dysphagia,6,16692559
9,22.0,Hypersensitivity,6,16692559
0,22.0,Stomatitis,6,16692563
1,22.0,Abdominal pain,6,16692563
2,22.0,Lipase increased,6,16692563
3,22.0,Anaemia,6,16692563
4,22.0,Fatigue,6,16692563
5,22.0,Nausea,6,16692563
6,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16692563
7,22.0,Lymphocyte count decreased,6,16692563
8,22.0,Pyrexia,6,16692563
9,22.0,Vomiting,6,16692563
0,22.1,Disease progression,,16692568
0,22.1,Upper limb fracture,6,16692584
1,22.1,Product dose omission,6,16692584
2,22.1,Feeling abnormal,2,16692584
3,22.1,Fall,6,16692584
4,22.1,Wrist fracture,6,16692584
5,22.1,Groin pain,6,16692584
6,22.1,Back pain,6,16692584
0,22.1,Pain,,16692602
0,22.1,Palpitations,,16692607
0,22.1,Seizure,,16692613
1,22.1,Dizziness,,16692613
0,22.1,Arthritis,2,16692660
0,22.0,Drug ineffective,6,16692663
1,22.0,Tumour marker increased,6,16692663
0,22.1,Erythema,1,16692740
1,22.1,Fluid intake reduced,3,16692740
2,22.1,Decreased appetite,3,16692740
3,22.1,Dyspnoea,3,16692740
4,22.1,Blood urine present,3,16692740
5,22.1,Colorectal cancer,3,16692740
6,22.1,Abdominal pain,3,16692740
7,22.1,Seizure,,16692740
8,22.1,Fatigue,3,16692740
9,22.1,Weight decreased,3,16692740
10,22.1,Pain in extremity,1,16692740
11,22.1,Weight increased,3,16692740
12,22.1,Metastases to central nervous system,3,16692740
13,22.1,Vomiting,3,16692740
14,22.1,Dehydration,3,16692740
15,22.1,Food refusal,3,16692740
16,22.1,White blood cell count increased,3,16692740
17,22.1,Off label use,,16692740
0,22.1,Fatigue,,16692743
0,22.0,Hypotension,1,16692753
1,22.0,Fall,1,16692753
0,22.1,Axillary vein thrombosis,1,16692791
1,22.1,Blepharitis,3,16692791
2,22.1,Subclavian vein thrombosis,1,16692791
0,22.1,Epistaxis,6,16692809
1,22.1,Drug ineffective,6,16692809
0,22.1,Diarrhoea,6,16692820
1,22.1,Pneumonia,1,16692820
2,22.1,Pneumocystis jirovecii pneumonia,1,16692820
0,22.0,Tooth erosion,3,16692840
0,22.0,Death,5,16692923
0,22.0,Rash,3,16692938
1,22.0,Device related infection,3,16692938
0,22.1,Medical device removal,1,16692976
1,22.1,Off label use,6,16692976
2,22.1,Decubitus ulcer,1,16692976
0,22.1,Interstitial lung disease,3,16692987
1,22.1,Deep vein thrombosis,2,16692987
2,22.1,Metastases to lymph nodes,3,16692987
3,22.1,Metastases to lung,3,16692987
0,22.0,Cardio-respiratory arrest,5,16692988
0,22.0,Large intestine perforation,5,16693002
0,22.0,Neutropenia,6,16693009
1,22.0,Death,5,16693009
0,22.0,Off label use,6,16693025
0,22.0,Off label use,6,16693036
1,22.0,Pain in extremity,6,16693036
2,22.0,Pain in jaw,6,16693036
3,22.0,Asthenia,6,16693036
4,22.0,Musculoskeletal pain,6,16693036
0,22.0,Intervertebral discitis,1,16693097
1,22.0,Polyneuropathy in malignant disease,3,16693097
2,22.0,Myalgia,3,16693097
3,22.0,Product use in unapproved indication,6,16693097
4,22.0,Off label use,6,16693097
5,22.0,Therapy partial responder,6,16693097
0,22.0,Metastases to lymph nodes,6,16693114
1,22.0,Metastases to bone,6,16693114
0,22.0,Breast cancer,3,16693115
1,22.0,Malignant neoplasm progression,3,16693115
0,22.0,Neutropenia,1,16693190
1,22.0,Thrombocytopenia,1,16693190
2,22.0,Alopecia,1,16693190
3,22.0,Anaemia,2,16693190
0,22.0,Hypoaesthesia,6,16693203
1,22.0,Seizure,6,16693203
2,22.0,Malignant neoplasm progression,6,16693203
0,22.0,Apical granuloma,2,16693213
0,22.0,Hypotension,1,16693325
1,22.0,Back pain,1,16693325
2,22.0,Pyrexia,1,16693325
0,22.0,Tachycardia,1,16693397
1,22.0,Back pain,1,16693397
2,22.0,Hypertension,1,16693397
3,22.0,Rash,1,16693397
0,22.0,Oedema,6,16693402
0,22.0,Death,5,16693412
0,22.0,Gastrointestinal perforation,6,16693419
1,22.0,Fatigue,6,16693419
0,22.0,Interstitial lung disease,2,16693424
0,22.0,Malignant neoplasm progression,3,16693427
0,22.1,Tumour pain,4,16693441
1,22.1,Anaemia,1,16693441
0,22.0,Acute myeloid leukaemia,1,16693451
0,22.0,Febrile neutropenia,6,16693452
1,22.0,Toxicity to various agents,6,16693452
0,22.0,Febrile neutropenia,6,16693458
1,22.0,Toxicity to various agents,6,16693458
0,22.0,Stomatitis,6,16693471
1,22.0,Toxicity to various agents,6,16693471
0,22.0,Full blood count decreased,6,16693472
1,22.0,Constipation,6,16693472
2,22.0,Dry mouth,2,16693472
3,22.0,Drug intolerance,6,16693472
4,22.0,Anaemia,3,16693472
5,22.0,Blood magnesium decreased,6,16693472
6,22.0,Fatigue,2,16693472
7,22.0,Underdose,6,16693472
0,22.0,Neutropenic sepsis,6,16693498
0,22.0,Apparent death,6,16693499
1,22.0,Malaise,6,16693499
2,22.0,Breast injury,6,16693499
3,22.0,Visual impairment,6,16693499
4,22.0,Lung neoplasm malignant,6,16693499
5,22.0,Wound infection,6,16693499
6,22.0,Neoplasm,6,16693499
7,22.0,Pain,6,16693499
8,22.0,Feeding disorder,6,16693499
9,22.0,Pyrexia,6,16693499
10,22.0,Drug ineffective,6,16693499
11,22.0,Cardiac dysfunction,6,16693499
12,22.0,Feeling abnormal,6,16693499
0,22.0,Death,5,16693507
0,22.0,Lower respiratory tract infection,6,16693512
0,22.0,Febrile neutropenia,1,16693522
0,22.0,Pneumocystis jirovecii pneumonia,5,16693525
0,22.0,Nephritis,2,16693527
0,22.0,Febrile neutropenia,6,16693534
1,22.0,Toxicity to various agents,6,16693534
0,22.0,Toxicity to various agents,6,16693539
1,22.0,Hepatitis,6,16693539
0,22.0,Transaminases increased,6,16693551
0,22.0,Respiratory failure,6,16693562
0,22.0,Pulmonary embolism,6,16693570
0,22.0,Pulmonary toxicity,6,16693582
1,22.0,Respiratory failure,6,16693582
0,22.0,Off label use,6,16693591
1,22.0,Hypocalcaemia,2,16693591
2,22.0,Acute kidney injury,2,16693591
3,22.0,Product use in unapproved indication,6,16693591
4,22.0,Hypomagnesaemia,2,16693591
0,22.0,Hirsutism,,16693595
0,22.0,Diarrhoea,6,16693598
1,22.0,Rectal ulcer,2,16693598
2,22.0,Lung neoplasm malignant,5,16693598
0,22.0,Upper respiratory tract infection,6,16693617
0,22.0,Pulmonary haemorrhage,1,16693626
0,22.0,Streptococcus test positive,3,16693678
0,22.0,Death,5,16693807
1,22.0,Off label use,1,16693807
2,22.0,Renal failure,6,16693807
0,22.0,Cerebral ischaemia,5,16693857
0,22.0,Febrile bone marrow aplasia,1,16693893
1,22.0,Diarrhoea,1,16693893
2,22.0,Clostridium difficile infection,1,16693893
3,22.0,Hypovolaemic shock,1,16693893
0,22.0,Nephritis,5,16693914
0,22.0,Toxicity to various agents,6,16694134
1,22.0,Oesophagitis,6,16694134
0,22.0,Haemodynamic instability,3,16694158
1,22.0,Neutropenic sepsis,5,16694158
2,22.0,Hypokalaemia,3,16694158
3,22.0,Metabolic acidosis,3,16694158
0,22.1,Anxiety,6,16694173
1,22.1,Pain,6,16694173
2,22.1,Emotional distress,6,16694173
3,22.1,Alopecia,3,16694173
4,22.1,Psychological trauma,6,16694173
5,22.1,Impaired quality of life,6,16694173
0,22.0,Paraesthesia,1,16694243
1,22.0,Staphylococcal infection,3,16694243
2,22.0,Osteomyelitis,1,16694243
3,22.0,Wound infection staphylococcal,3,16694243
0,22.0,Oesophageal perforation,5,16694254
1,22.0,Toxicity to various agents,5,16694254
0,22.0,Leukopenia,3,16694289
1,22.0,Thrombocytopenia,3,16694289
2,22.0,Anaemia,3,16694289
0,22.0,Toxicity to various agents,5,16694298
1,22.0,Pneumonitis,5,16694298
0,22.1,Photosensitivity reaction,1,16694305
0,22.0,Haemoptysis,1,16694332
0,22.1,Hair colour changes,3,16694360
1,22.1,Alopecia,3,16694360
2,22.1,Hair texture abnormal,3,16694360
3,22.1,Hair disorder,3,16694360
4,22.1,Madarosis,3,16694360
0,22.0,Neoplasm progression,6,16694374
0,22.0,Cardiotoxicity,6,16694407
1,22.0,Ejection fraction decreased,6,16694407
0,22.0,Acute respiratory failure,1,16694418
0,22.0,Sudden hearing loss,3,16694470
1,22.0,Hyperhidrosis,6,16694470
2,22.0,Rash,6,16694470
3,22.0,Paraesthesia,6,16694470
0,22.0,Diverticulitis,1,16694486
1,22.0,Abdominal pain lower,6,16694486
0,22.0,Pyrexia,4,16694487
1,22.0,Eye swelling,4,16694487
2,22.0,Pain,4,16694487
3,22.0,Nausea,2,16694487
4,22.0,Urinary incontinence,1,16694487
5,22.0,Visual impairment,4,16694487
6,22.0,Vomiting,2,16694487
7,22.0,Hypertension,1,16694487
8,22.0,Bone pain,2,16694487
9,22.0,Chills,4,16694487
0,22.0,Decubitus ulcer,1,16694500
0,22.1,Chronic obstructive pulmonary disease,6,16694526
0,22.0,Gastric disorder,6,16694535
1,22.0,Coeliac disease,6,16694535
0,22.0,Asthenia,6,16694550
1,22.0,Drug ineffective,6,16694550
2,22.0,Fatigue,6,16694550
3,22.0,Decreased appetite,6,16694550
4,22.0,Pulmonary embolism,6,16694550
0,22.0,Urinary incontinence,3,16694581
1,22.0,Cough,1,16694581
2,22.0,Pruritus,1,16694581
3,22.0,Pneumonia aspiration,1,16694581
4,22.0,Laryngeal oedema,3,16694581
5,22.0,Poikiloderma,3,16694581
6,22.0,Hypokinesia,1,16694581
7,22.0,Myopathy,3,16694581
8,22.0,Dyspnoea,3,16694581
9,22.0,Aspiration,3,16694581
10,22.0,Neuropathy peripheral,1,16694581
11,22.0,Stridor,3,16694581
12,22.0,Urinary tract infection,3,16694581
13,22.0,Bone pain,1,16694581
14,22.0,Eyelid ptosis,3,16694581
15,22.0,Urticaria,3,16694581
16,22.0,Stomatitis,1,16694581
17,22.0,Myositis,3,16694581
18,22.0,Gait disturbance,3,16694581
19,22.0,Condition aggravated,3,16694581
20,22.0,Fungal infection,3,16694581
21,22.0,Pain,3,16694581
22,22.0,Swelling of eyelid,3,16694581
23,22.0,Abdominal pain upper,1,16694581
24,22.0,Face oedema,3,16694581
25,22.0,General physical health deterioration,3,16694581
26,22.0,Vocal cord paralysis,3,16694581
27,22.0,Pleural effusion,1,16694581
28,22.0,Dysphonia,1,16694581
29,22.0,Epistaxis,1,16694581
30,22.0,Muscular weakness,1,16694581
31,22.0,Dysphagia,3,16694581
32,22.0,Weight decreased,3,16694581
33,22.0,Painful respiration,1,16694581
34,22.0,Nail disorder,1,16694581
0,22.1,Hepatic encephalopathy,6,16694590
1,22.1,Squamous cell carcinoma of skin,1,16694590
2,22.1,Plasmacytoma,6,16694590
0,22.0,Cardiotoxicity,6,16694681
0,22.0,Blister,3,16694778
1,22.0,Abdominal discomfort,3,16694778
2,22.0,Perirectal abscess,1,16694778
3,22.0,Taste disorder,3,16694778
4,22.0,Diarrhoea,3,16694778
5,22.0,Fatigue,3,16694778
6,22.0,Anal fistula,1,16694778
7,22.0,Renal function test abnormal,3,16694778
8,22.0,Weight decreased,3,16694778
9,22.0,Nausea,3,16694778
10,22.0,Asthenia,3,16694778
11,22.0,Skin ulcer,3,16694778
12,22.0,Decreased appetite,3,16694778
13,22.0,Vision blurred,3,16694778
14,22.0,Gastrooesophageal reflux disease,3,16694778
15,22.0,Blood sodium decreased,3,16694778
16,22.0,Blood pressure increased,3,16694778
0,22.0,Pharyngeal swelling,6,16694779
1,22.0,Constipation,1,16694779
2,22.0,Dysphagia,6,16694779
3,22.0,Pyrexia,6,16694779
0,22.0,Hyperglycaemia,1,16694809
1,22.0,Rash generalised,1,16694809
2,22.0,Dysuria,1,16694809
0,22.0,Drug eruption,1,16694835
0,22.0,Drug ineffective,5,16694860
0,22.0,Chest discomfort,6,16694868
1,22.0,Diarrhoea,6,16694868
0,22.0,Drug resistance,6,16694939
1,22.0,Non-small cell lung cancer stage IV,6,16694939
2,22.0,Malignant neoplasm progression,6,16694939
3,22.0,Diarrhoea,1,16694939
0,22.1,Pain in extremity,3,16694944
1,22.1,Flank pain,3,16694944
2,22.1,Hepatic enzyme increased,1,16694944
3,22.1,Pyrexia,1,16694944
4,22.1,Paraesthesia,2,16694944
5,22.1,Dizziness,3,16694944
6,22.1,Dyspnoea,1,16694944
7,22.1,Asthenia,3,16694944
8,22.1,Fatigue,2,16694944
9,22.1,Arthralgia,3,16694944
10,22.1,Glomerular filtration rate decreased,1,16694944
11,22.1,Drug resistance,3,16694944
12,22.1,Hypoaesthesia,3,16694944
13,22.1,Headache,3,16694944
14,22.1,Metastases to spine,3,16694944
15,22.1,Influenza like illness,2,16694944
16,22.1,Vision blurred,2,16694944
17,22.1,Discomfort,2,16694944
18,22.1,Hepatic enzyme abnormal,1,16694944
19,22.1,Palpitations,2,16694944
20,22.1,Lacrimation increased,2,16694944
21,22.1,Oedema peripheral,1,16694944
22,22.1,Malignant neoplasm progression,3,16694944
23,22.1,Cardiac disorder,2,16694944
24,22.1,Arthropathy,1,16694944
25,22.1,Tumour marker increased,3,16694944
26,22.1,Hypokinesia,1,16694944
0,22.0,Death,5,16695018
0,22.0,Blood albumin decreased,2,16695043
0,22.0,Hypersensitivity,2,16695052
1,22.0,Vomiting,2,16695052
0,22.0,Death,5,16695076
0,22.0,Asthenia,6,16695248
1,22.0,Fatigue,6,16695248
2,22.0,Malaise,6,16695248
3,22.0,Mycobacterium chelonae infection,1,16695248
4,22.0,Tenosynovitis,1,16695248
5,22.0,Nausea,6,16695248
6,22.0,Toxicity to various agents,6,16695248
7,22.0,Pancytopenia,6,16695248
0,22.0,Abdominal infection,6,16695271
0,22.0,Posterior reversible encephalopathy syndrome,6,16695313
0,22.0,Skin reaction,2,16695319
0,22.0,Malignant neoplasm progression,6,16695335
1,22.0,Tumour associated fever,1,16695335
2,22.0,Tumour invasion,1,16695335
0,22.0,Sepsis,5,16695343
1,22.0,Perforation,5,16695343
2,22.0,Neuropathy peripheral,6,16695343
3,22.0,Thrombocytopenia,6,16695343
0,22.0,Multiple-drug resistance,6,16695347
0,22.0,Peripheral sensory neuropathy,6,16695348
1,22.0,Multiple-drug resistance,6,16695348
0,22.0,Constipation,6,16695356
1,22.0,Hyperammonaemia,1,16695356
2,22.0,Decreased appetite,6,16695356
3,22.0,Dehydration,6,16695356
0,22.0,Multiple-drug resistance,6,16695368
0,22.0,Bone marrow failure,2,16695379
0,22.0,Bone marrow failure,3,16695405
0,22.0,Drug interaction,5,16695408
1,22.0,Gastrointestinal perforation,5,16695408
0,22.0,Hepatic function abnormal,1,16695504
0,22.0,Diarrhoea,6,16695506
1,22.0,Headache,6,16695506
2,22.0,Product dose omission,6,16695506
3,22.0,Pruritus generalised,6,16695506
4,22.0,Bone marrow failure,6,16695506
5,22.0,Rectal haemorrhage,6,16695506
6,22.0,Leukopenia,6,16695506
7,22.0,Haemorrhoidal haemorrhage,1,16695506
0,22.0,Escherichia sepsis,1,16695522
1,22.0,Febrile neutropenia,1,16695522
0,22.0,Anaemia,6,16695581
1,22.0,Dermatitis,6,16695581
0,22.0,Bedridden,6,16695603
1,22.0,Drug ineffective,1,16695603
2,22.0,Radiation injury,6,16695603
0,22.0,Multiple-drug resistance,6,16695627
0,22.0,Tubulointerstitial nephritis,6,16695640
0,22.0,Diarrhoea,6,16695657
1,22.0,Fatigue,6,16695657
2,22.0,Nausea,6,16695657
3,22.0,Pain,6,16695657
4,22.0,Peripheral sensory neuropathy,6,16695657
5,22.0,Pyrexia,6,16695657
6,22.0,Platelet count decreased,6,16695657
7,22.0,Vomiting,6,16695657
8,22.0,Sepsis,6,16695657
9,22.0,Acute kidney injury,6,16695657
10,22.0,Blood alkaline phosphatase increased,6,16695657
11,22.0,Decreased appetite,6,16695657
12,22.0,Neutrophil count decreased,6,16695657
13,22.0,Weight decreased,6,16695657
14,22.0,Embolism,6,16695657
15,22.0,Abdominal pain,6,16695657
16,22.0,Skin infection,6,16695657
0,22.0,Tumour haemorrhage,6,16695664
0,22.0,Tumour lysis syndrome,6,16695668
0,22.0,Death,5,16695683
1,22.0,Anaemia,2,16695683
0,22.0,Death,5,16695688
0,22.0,Musculoskeletal stiffness,6,16695714
1,22.0,Diabetes mellitus,6,16695714
2,22.0,Hepatomegaly,6,16695714
3,22.0,Lymphoedema,6,16695714
0,22.1,Jaundice,2,16695721
1,22.1,Malignant neoplasm progression,5,16695721
2,22.1,Cholangitis sclerosing,1,16695721
0,22.0,Product use complaint,6,16695774
0,22.0,Type I hypersensitivity,1,16695823
0,22.0,Bladder irritation,1,16695862
1,22.0,Muscle spasms,1,16695862
2,22.0,Arthralgia,1,16695862
3,22.0,Dysphonia,1,16695862
4,22.0,Speech disorder,1,16695862
5,22.0,Insomnia,3,16695862
6,22.0,Product use issue,6,16695862
7,22.0,Urinary tract infection,1,16695862
8,22.0,Neuropathy peripheral,1,16695862
9,22.0,Injection site discomfort,6,16695862
10,22.0,Injection site pain,1,16695862
11,22.0,Cough,1,16695862
12,22.0,Dyspnoea,1,16695862
13,22.0,Sensation of foreign body,1,16695862
14,22.0,Injection site mass,1,16695862
15,22.0,Headache,1,16695862
16,22.0,Fatigue,2,16695862
17,22.0,Vomiting,1,16695862
0,22.0,Hypocalcaemia,1,16695873
1,22.0,Hypophosphataemia,1,16695873
2,22.0,Fibroblast growth factor 23 increased,1,16695873
3,22.0,Blood alkaline phosphatase increased,1,16695873
4,22.0,Blood parathyroid hormone increased,1,16695873
5,22.0,Tumour marker increased,1,16695873
6,22.0,Hypophosphataemic osteomalacia,1,16695873
7,22.0,Electrolyte imbalance,1,16695873
0,22.0,Dialysis,1,16695879
1,22.0,Device programming error,1,16695879
2,22.0,Product administration error,1,16695879
3,22.0,Wrong rate,1,16695879
0,22.0,Septic shock,6,16695880
1,22.0,Diarrhoea,6,16695880
2,22.0,Neutropenic colitis,6,16695880
3,22.0,Nausea,6,16695880
4,22.0,Neutropenia,6,16695880
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,16695962
1,22.1,Interstitial lung disease,2,16695962
0,22.0,Cardio-respiratory arrest,6,16695976
1,22.0,Escherichia infection,6,16695976
2,22.0,Lumbar spinal stenosis,6,16695976
3,22.0,Death,5,16695976
4,22.0,Motor dysfunction,1,16695976
5,22.0,Electrocardiogram PR prolongation,6,16695976
6,22.0,Pyrexia,6,16695976
7,22.0,Atrioventricular block,6,16695976
8,22.0,Paraesthesia,6,16695976
9,22.0,Fall,6,16695976
10,22.0,Urinary tract infection,6,16695976
11,22.0,Loss of consciousness,6,16695976
0,22.0,Seizure,1,16696012
0,22.0,Blood pressure increased,6,16696034
1,22.0,Asthenia,6,16696034
2,22.0,Fatigue,2,16696034
0,22.0,Lung disorder,3,16696053
0,22.0,Drug ineffective,6,16696076
1,22.0,White blood cell count decreased,3,16696076
2,22.0,Malignant neoplasm progression,3,16696076
0,22.0,Pancytopenia,6,16696129
0,22.0,Ischaemic stroke,1,16696177
1,22.0,Deep vein thrombosis,1,16696177
0,22.1,Dermatitis,3,16696186
1,22.1,Eosinophil count increased,3,16696186
0,22.0,Dementia,6,16696211
0,22.0,White blood cell count decreased,6,16696224
1,22.0,Vomiting,6,16696224
2,22.0,Haemoglobin decreased,6,16696224
3,22.0,Hepatic function abnormal,6,16696224
4,22.0,Nausea,6,16696224
5,22.0,Renal impairment,6,16696224
0,22.0,White blood cells urine positive,6,16696245
1,22.0,Pyrexia,6,16696245
2,22.0,Urinary tract infection,1,16696245
3,22.0,Urinary tract infection,1,16696245
4,22.0,Urinary tract infection,1,16696245
5,22.0,Red blood cells urine positive,6,16696245
0,22.0,Pneumonia,5,16696367
0,22.0,Dyspnoea,6,16696393
1,22.0,Death,5,16696393
2,22.0,Asthenia,6,16696393
3,22.0,Back pain,6,16696393
4,22.0,Speech disorder,6,16696393
0,22.0,Uterine cancer,6,16696447
1,22.0,Adverse drug reaction,6,16696447
2,22.0,Blood glucose fluctuation,6,16696447
3,22.0,Off label use,6,16696447
0,22.0,Death,5,16696458
0,22.0,Urinary tract infection,1,16696504
1,22.0,Thrombosis,1,16696504
2,22.0,Visual field defect,1,16696504
3,22.0,Neutropenia,1,16696504
4,22.0,Leukopenia,1,16696504
0,22.1,Hepatic function abnormal,2,16696542
0,22.1,Febrile neutropenia,1,16696547
1,22.1,Rash,1,16696547
0,22.0,Myocardial infarction,1,16696554
1,22.0,Anaemia,1,16696554
2,22.0,Troponin increased,1,16696554
0,22.1,Palpitations,3,16696570
1,22.1,Dizziness,3,16696570
2,22.1,Hyperhidrosis,3,16696570
0,22.1,Lower respiratory tract infection,1,16696571
1,22.1,Pulmonary oedema,1,16696571
2,22.1,Neutropenic sepsis,1,16696571
0,22.0,Depression,6,16696583
0,22.0,Dyspnoea,6,16696595
1,22.0,Asthma,6,16696595
2,22.0,Constipation,3,16696595
3,22.0,Nausea,6,16696595
4,22.0,Vomiting,6,16696595
5,22.0,Cholelithiasis,6,16696595
6,22.0,Abdominal distension,6,16696595
7,22.0,Dyspnoea,2,16696595
8,22.0,Dyspepsia,6,16696595
9,22.0,Pleural effusion,6,16696595
10,22.0,Confusional state,6,16696595
0,22.0,Acute myeloid leukaemia,3,16696632
1,22.0,Emotional disorder,3,16696632
0,22.1,Malignant neoplasm progression,6,16696802
1,22.1,Cognitive disorder,6,16696802
2,22.1,Hepatic cancer,6,16696802
3,22.1,Gastric cancer,6,16696802
0,22.1,Pain in extremity,,16696821
1,22.1,Erythema,,16696821
2,22.1,Swelling,,16696821
0,22.0,Rash,6,16696887
0,22.1,Platelet count decreased,1,16696911
1,22.1,Haematocrit decreased,1,16696911
2,22.1,Full blood count decreased,1,16696911
3,22.1,Haemoglobin decreased,1,16696911
0,22.0,Hair disorder,3,16696915
1,22.0,Alopecia,3,16696915
2,22.0,Hair colour changes,3,16696915
3,22.0,Hair texture abnormal,3,16696915
4,22.0,Madarosis,3,16696915
0,22.1,Nasopharyngitis,6,16696919
1,22.1,Pneumonia,3,16696919
2,22.1,Herpes simplex,1,16696919
3,22.1,Cough,1,16696919
0,22.1,Constipation,6,16696923
1,22.1,Nausea,6,16696923
2,22.1,Acne,6,16696923
3,22.1,Chills,6,16696923
4,22.1,Vomiting,6,16696923
5,22.1,Pruritus,6,16696923
0,22.1,Dry eye,3,16696927
1,22.1,Feeling abnormal,3,16696927
2,22.1,Asthenia,3,16696927
3,22.1,Balance disorder,3,16696927
0,22.0,Nausea,6,16696929
0,22.1,Taste disorder,3,16696930
1,22.1,Peripheral swelling,3,16696930
0,22.0,Product storage error,6,16696951
1,22.0,Neoplasm progression,2,16696951
2,22.0,Poor quality product administered,6,16696951
0,22.1,Alopecia,3,16696969
1,22.1,Oedema peripheral,3,16696969
0,22.0,Renal failure,6,16697010
1,22.0,General physical health deterioration,3,16697010
0,22.0,Tumour lysis syndrome,6,16697016
0,22.1,Oxygen saturation decreased,6,16697046
1,22.1,White blood cell count decreased,6,16697046
2,22.1,Upper limb fracture,6,16697046
3,22.1,Hot flush,6,16697046
4,22.1,Fall,6,16697046
5,22.1,Headache,6,16697046
6,22.1,Rhinorrhoea,6,16697046
7,22.1,Loss of consciousness,6,16697046
8,22.1,Platelet count decreased,6,16697046
9,22.1,Pain in jaw,6,16697046
10,22.1,Eye discharge,6,16697046
11,22.1,Product dose omission,6,16697046
12,22.1,Rib fracture,6,16697046
13,22.1,Anaemia,6,16697046
14,22.1,Hypotension,6,16697046
15,22.1,Pain,6,16697046
16,22.1,Alopecia,2,16697046
17,22.1,Spinal fracture,6,16697046
18,22.1,Tumour marker abnormal,6,16697046
0,22.0,Weight increased,6,16697056
1,22.0,Neuropathy peripheral,6,16697056
2,22.0,Neoplasm progression,6,16697056
3,22.0,Ocular discomfort,6,16697056
0,22.1,Movement disorder,3,16697060
1,22.1,Musculoskeletal stiffness,3,16697060
2,22.1,Parkinsonism,6,16697060
3,22.1,Trigger finger,6,16697060
0,22.0,Neoplasm progression,6,16697068
0,22.0,Loss of consciousness,1,16697075
1,22.0,Contraindicated product administered,6,16697075
2,22.0,Feeling abnormal,6,16697075
3,22.0,Reaction to excipient,1,16697075
4,22.0,Drug hypersensitivity,1,16697075
0,22.0,Drug effective for unapproved indication,6,16697083
1,22.0,Off label use,6,16697083
0,22.0,Neoplasm progression,6,16697091
1,22.0,Condition aggravated,6,16697091
2,22.0,Pericardial effusion,6,16697091
0,22.0,Dyspnoea,1,16697094
1,22.0,Hypersensitivity,1,16697094
2,22.0,Bronchospasm,1,16697094
3,22.0,Tachycardia,1,16697094
4,22.0,Oedema,1,16697094
5,22.0,Headache,1,16697094
6,22.0,Dyspepsia,1,16697094
7,22.0,Chest discomfort,1,16697094
0,22.0,Malignant neoplasm progression,5,16697110
0,22.0,Bone marrow disorder,6,16697135
1,22.0,Acquired gene mutation,6,16697135
0,22.0,Muscular weakness,6,16697160
1,22.0,Ulcer,6,16697160
2,22.0,Blister,6,16697160
3,22.0,Fatigue,6,16697160
4,22.0,Peripheral swelling,6,16697160
0,22.0,Dizziness,6,16697172
1,22.0,Neoplasm progression,6,16697172
0,22.0,Acquired gene mutation,6,16697229
1,22.0,Bone marrow disorder,6,16697229
0,22.0,Bone marrow disorder,6,16697230
1,22.0,Acquired gene mutation,6,16697230
0,22.0,Bone marrow disorder,6,16697234
1,22.0,Acquired gene mutation,6,16697234
0,22.0,Multiple organ dysfunction syndrome,5,16697242
1,22.0,Acute myeloid leukaemia,5,16697242
0,22.0,Bone marrow disorder,6,16697260
1,22.0,Acquired gene mutation,6,16697260
0,22.0,Abscess,5,16697268
1,22.0,Gastrointestinal perforation,5,16697268
2,22.0,Neutropenic infection,5,16697268
3,22.0,Thrombocytopenia,5,16697268
4,22.0,Anaemia,5,16697268
5,22.0,Proteinuria,5,16697268
6,22.0,Cerebrovascular accident,5,16697268
7,22.0,Impaired healing,5,16697268
8,22.0,Palmar-plantar erythrodysaesthesia syndrome,5,16697268
9,22.0,Fistula,5,16697268
10,22.0,Neutropenia,5,16697268
11,22.0,Cardiac failure congestive,5,16697268
12,22.0,Haemorrhage,5,16697268
13,22.0,Sepsis,5,16697268
14,22.0,Hypertension,5,16697268
15,22.0,Embolism,5,16697268
16,22.0,Intestinal perforation,5,16697268
0,22.0,Neutrophil count decreased,6,16697321
1,22.0,Leukopenia,6,16697321
2,22.0,Discomfort,6,16697321
3,22.0,Rash,6,16697321
0,22.0,Acquired gene mutation,6,16697349
1,22.0,Bone marrow disorder,6,16697349
0,22.0,Hair growth abnormal,6,16697350
0,22.0,Bone marrow disorder,6,16697359
1,22.0,Acquired gene mutation,6,16697359
0,22.0,Neoplasm progression,6,16697375
0,22.0,Neoplasm progression,6,16697376
0,22.1,Transaminases increased,3,16697408
0,22.1,Thrombocytopenia,1,16697417
0,22.0,Death,5,16697492
0,22.0,Death,5,16697499
0,22.0,Neutropenia,3,16697512
0,22.0,Neutropenia,1,16697520
0,22.0,Deep vein thrombosis,1,16697535
1,22.0,Ischaemic stroke,1,16697535
0,22.0,Heart rate decreased,6,16697546
0,22.1,Death,,16697595
0,22.1,Malignant neoplasm progression,,16697602
0,22.1,Pancreatitis,,16697618
0,22.0,Coeliac disease,6,16697619
1,22.0,C-telopeptide increased,6,16697619
2,22.0,Abdominal discomfort,6,16697619
0,22.0,Thyroglobulin increased,6,16697625
1,22.0,Rash,6,16697625
2,22.0,Cholecystitis,6,16697625
3,22.0,Malignant neoplasm progression,6,16697625
4,22.0,Papillary thyroid cancer,6,16697625
5,22.0,Pyrexia,6,16697625
0,22.1,Diarrhoea,6,16697633
1,22.1,Abdominal pain,6,16697633
2,22.1,Inflammation,6,16697633
3,22.1,Pain in extremity,6,16697633
4,22.1,Abdominal pain upper,6,16697633
5,22.1,Malaise,6,16697633
6,22.1,Thrombophlebitis,2,16697633
7,22.1,Impaired healing,6,16697633
8,22.1,Arthropod bite,6,16697633
9,22.1,Gastrointestinal disorder,6,16697633
10,22.1,Feeling abnormal,6,16697633
11,22.1,Dysstasia,6,16697633
12,22.1,Peripheral swelling,6,16697633
13,22.1,Renal disorder,6,16697633
14,22.1,Inappropriate schedule of product administration,6,16697633
15,22.1,Headache,6,16697633
16,22.1,Influenza,6,16697633
0,22.0,Diarrhoea,1,16697636
1,22.0,Venous thrombosis limb,1,16697636
2,22.0,Tooth development disorder,6,16697636
3,22.0,General physical health deterioration,1,16697636
4,22.0,Fatigue,1,16697636
0,22.0,Product dose omission,6,16697677
0,22.0,Neutropenia,6,16697678
0,22.0,Ocular hyperaemia,2,16697680
1,22.0,Dacryostenosis acquired,2,16697680
2,22.0,Lacrimation increased,2,16697680
3,22.0,Dry eye,2,16697680
4,22.0,Eye irritation,2,16697680
0,22.1,Fatigue,,16697694
0,22.1,Burns third degree,,16697695
0,22.0,Stomatitis,1,16697709
1,22.0,Pain,3,16697709
2,22.0,Pancytopenia,1,16697709
0,22.0,Cachexia,5,16697738
1,22.0,Performance status decreased,5,16697738
0,22.0,Neoplasm progression,6,16697776
1,22.0,Drug resistance,6,16697776
0,22.0,Liver function test increased,6,16697784
0,22.0,Radiation pneumonitis,2,16697785
0,22.0,Abdominal hernia,3,16697820
1,22.0,Hemiparesis,3,16697820
2,22.0,Pain in extremity,6,16697820
3,22.0,Musculoskeletal pain,6,16697820
0,22.1,Dizziness,6,16697828
1,22.1,Oropharyngeal pain,6,16697828
2,22.1,Deep vein thrombosis,6,16697828
3,22.1,Dyspnoea,3,16697828
4,22.1,Diarrhoea,6,16697828
5,22.1,Pain in extremity,6,16697828
6,22.1,Fatigue,3,16697828
7,22.1,Weight decreased,6,16697828
8,22.1,Dysphonia,6,16697828
0,22.0,Hepatocellular injury,3,16697833
0,22.0,Death,5,16697835
0,22.0,Dermatitis,6,16697843
1,22.0,Anaemia,6,16697843
0,22.1,Febrile neutropenia,1,16697859
0,22.0,Pulmonary embolism,5,16697912
1,22.0,Adverse event,3,16697912
2,22.0,Pain,3,16697912
0,22.1,Back pain,1,16697923
1,22.1,Anaemia,1,16697923
2,22.1,Bone pain,3,16697923
0,22.1,Seizure,6,16697929
1,22.1,Inflammation,3,16697929
2,22.1,Emphysema,6,16697929
3,22.1,Disease recurrence,6,16697929
4,22.1,Swelling,6,16697929
5,22.1,Neoplasm progression,6,16697929
6,22.1,Lymphadenopathy,6,16697929
7,22.1,Atypical pneumonia,6,16697929
8,22.1,Peripheral swelling,3,16697929
9,22.1,Musculoskeletal discomfort,6,16697929
10,22.1,Ear discomfort,6,16697929
0,22.0,Herpes zoster,1,16697933
1,22.0,Dizziness,3,16697933
0,22.1,Malaise,1,16697945
1,22.1,Pulmonary oedema,3,16697945
0,22.0,Discomfort,5,16697950
0,22.0,Product use in unapproved indication,6,16697962
1,22.0,Respiratory distress,1,16697962
0,22.0,Gastric haemorrhage,2,16697965
0,22.0,Malignant neoplasm progression,6,16697969
1,22.0,Metastases to soft tissue,6,16697969
2,22.0,Metastases to lung,6,16697969
0,22.1,Pneumonia,6,16697976
1,22.1,Vomiting,6,16697976
2,22.1,Nausea,3,16697976
3,22.1,Neoplasm progression,6,16697976
4,22.1,Fatigue,6,16697976
5,22.1,Dyspnoea,1,16697976
6,22.1,Abdominal discomfort,6,16697976
0,22.1,Death,5,16697978
0,22.0,Hypotension,1,16698011
1,22.0,Fall,1,16698011
0,22.1,Gastric perforation,1,16698012
0,22.1,Rash,1,16698018
0,22.1,Myalgia,6,16698034
1,22.1,Pyrexia,3,16698034
2,22.1,Limb injury,6,16698034
3,22.1,Neoplasm progression,6,16698034
4,22.1,Pain,6,16698034
5,22.1,Scab,3,16698034
6,22.1,Skin lesion,3,16698034
0,22.1,Abdominal pain,6,16698061
1,22.1,White blood cell count decreased,1,16698061
2,22.1,Vomiting,3,16698061
3,22.1,Platelet count decreased,1,16698061
4,22.1,Lymphocyte count decreased,1,16698061
5,22.1,Diarrhoea,3,16698061
6,22.1,Aspartate aminotransferase increased,1,16698061
7,22.1,Alanine aminotransferase increased,1,16698061
8,22.1,Blood alkaline phosphatase increased,1,16698061
0,22.0,Metastases to pleura,2,16698063
1,22.0,Gastrointestinal disorder,2,16698063
2,22.0,Hypersensitivity,1,16698063
3,22.0,Neoplasm progression,1,16698063
4,22.0,Erythema,1,16698063
5,22.0,Nodule,2,16698063
6,22.0,Skin ulcer,1,16698063
7,22.0,Adenocarcinoma,2,16698063
8,22.0,Tumour embolism,2,16698063
9,22.0,Breast oedema,1,16698063
10,22.0,Inflammation,1,16698063
11,22.0,Ill-defined disorder,1,16698063
12,22.0,Skin texture abnormal,1,16698063
13,22.0,Neoplasm malignant,2,16698063
14,22.0,Metastasis,2,16698063
15,22.0,Breast inflammation,2,16698063
16,22.0,Skin wound,1,16698063
17,22.0,Pain,1,16698063
18,22.0,Skin mass,2,16698063
19,22.0,Metastases to peritoneum,2,16698063
0,22.0,Sepsis,1,16698078
1,22.0,Febrile neutropenia,6,16698078
2,22.0,Malaise,6,16698078
3,22.0,Haematuria,6,16698078
4,22.0,Alopecia,6,16698078
5,22.0,Peripheral sensory neuropathy,6,16698078
6,22.0,Diarrhoea,6,16698078
7,22.0,Lower gastrointestinal haemorrhage,6,16698078
8,22.0,Hiccups,6,16698078
9,22.0,Nausea,6,16698078
10,22.0,Pyelonephritis,1,16698078
11,22.0,Decreased appetite,6,16698078
12,22.0,Urinary tract infection,6,16698078
0,22.1,Interstitial lung disease,6,16698158
0,22.0,Glossitis,3,16698186
1,22.0,Gallbladder disorder,1,16698186
2,22.0,Swelling face,3,16698186
3,22.0,Malignant neoplasm progression,3,16698186
4,22.0,Toothache,3,16698186
5,22.0,Stomatitis,3,16698186
6,22.0,Dry throat,3,16698186
7,22.0,Musculoskeletal pain,3,16698186
8,22.0,Blood pressure increased,3,16698186
9,22.0,Pneumonia,6,16698186
10,22.0,Asthenia,6,16698186
11,22.0,Pain in jaw,3,16698186
0,22.0,Neoplasm malignant,5,16698265
0,22.0,Interstitial lung disease,1,16698273
1,22.0,Metastases to lung,6,16698273
0,22.0,Myositis,2,16698291
1,22.0,Orbital myositis,2,16698291
0,22.0,Drug ineffective,6,16698299
1,22.0,Hyperaesthesia,2,16698299
0,22.0,Dysphonia,,16698301
1,22.0,Hospitalisation,,16698301
2,22.0,Erythema,,16698301
3,22.0,Feeling abnormal,,16698301
4,22.0,Pain in extremity,,16698301
5,22.0,Generalised erythema,,16698301
6,22.0,Dizziness,,16698301
7,22.0,Musculoskeletal stiffness,,16698301
8,22.0,Pigmentation disorder,,16698301
0,22.1,Pain,2,16698303
1,22.1,Dysphonia,3,16698303
2,22.1,Colorectal cancer metastatic,,16698303
3,22.1,Fatigue,2,16698303
4,22.1,Off label use,,16698303
5,22.1,Chest pain,2,16698303
6,22.1,Hypersomnia,,16698303
7,22.1,Rash,2,16698303
8,22.1,Tumour marker abnormal,3,16698303
9,22.1,Sepsis,2,16698303
0,22.1,Blood alkaline phosphatase increased,1,16698308
1,22.1,Aspartate aminotransferase increased,1,16698308
2,22.1,Alanine aminotransferase increased,3,16698308
0,22.0,Renal impairment,6,16698328
1,22.0,Oedema,3,16698328
0,22.0,Haematochezia,2,16698344
1,22.0,Abdominal pain,2,16698344
2,22.0,Bone marrow failure,2,16698344
3,22.0,Gastrointestinal haemorrhage,1,16698344
4,22.0,Diarrhoea,2,16698344
0,22.1,Second primary malignancy,3,16698345
1,22.1,Febrile neutropenia,3,16698345
2,22.1,Pancytopenia,3,16698345
3,22.1,Neutropenia,3,16698345
4,22.1,Acute myeloid leukaemia,3,16698345
0,22.0,Haemolysis,6,16698350
0,22.0,Pancytopenia,6,16698380
0,22.1,Death,5,16698399
1,22.1,Intentional product use issue,6,16698399
0,22.0,Post procedural complication,5,16698439
1,22.0,Malignant neoplasm progression,5,16698439
2,22.0,Product use in unapproved indication,6,16698439
3,22.0,Off label use,6,16698439
0,22.0,Thrombocytopenia,6,16698461
1,22.0,Neutropenia,6,16698461
2,22.0,Anaemia,6,16698461
3,22.0,Haematotoxicity,6,16698461
0,22.0,Decreased appetite,6,16698463
1,22.0,Nausea,1,16698463
2,22.0,Hepatic function abnormal,2,16698463
3,22.0,Vomiting,1,16698463
4,22.0,Bone marrow failure,2,16698463
0,22.0,Febrile neutropenia,1,16698486
1,22.0,Granulocytopenia,1,16698486
2,22.0,Neoplasm progression,6,16698486
0,22.0,Pneumonia,2,16698488
1,22.0,Sepsis,6,16698488
2,22.0,Pancytopenia,6,16698488
0,22.0,Prostatic specific antigen increased,3,16698489
1,22.0,Thrombocytopenia,3,16698489
2,22.0,Leukopenia,3,16698489
0,22.0,Genital burning sensation,3,16698490
1,22.0,Pelvic pain,3,16698490
0,22.0,Transurethral prostatectomy,6,16698555
0,22.0,Musculoskeletal stiffness,3,16698560
1,22.0,Discomfort,3,16698560
0,22.1,Neoplasm progression,3,16698569
0,22.1,Pain,3,16698573
1,22.1,Hypoacusis,6,16698573
2,22.1,Fatigue,3,16698573
0,22.1,Condition aggravated,6,16698613
1,22.1,Interstitial lung disease,2,16698613
2,22.1,Myocarditis,5,16698613
3,22.1,Adrenal insufficiency,3,16698613
4,22.1,Thyroid disorder,2,16698613
5,22.1,Malignant neoplasm progression,5,16698613
0,22.1,Psychiatric symptom,6,16698617
1,22.1,Hepatic function abnormal,2,16698617
2,22.1,Prostate cancer,6,16698617
3,22.1,Hospitalisation,6,16698617
4,22.1,Aortic valve incompetence,6,16698617
0,22.0,Pyrexia,4,16698626
1,22.0,Vomiting,4,16698626
2,22.0,Post procedural inflammation,4,16698626
0,22.0,Coronary artery disease,1,16698696
0,22.0,Drug ineffective,6,16698733
0,22.0,Pancytopenia,6,16698766
0,22.0,Wrong technique in device usage process,6,16698767
1,22.0,High density lipoprotein increased,2,16698767
2,22.0,Transient ischaemic attack,6,16698767
3,22.0,Device issue,6,16698767
4,22.0,Prostate cancer,6,16698767
5,22.0,Glycosylated haemoglobin increased,2,16698767
0,22.0,Multiple organ dysfunction syndrome,5,16698771
0,22.0,Somnolence,2,16698786
1,22.0,Delirium,2,16698786
0,22.1,Nausea,1,16698845
1,22.1,Hypertension,1,16698845
2,22.1,Vomiting,1,16698845
3,22.1,Interstitial lung disease,1,16698845
0,22.0,Drug ineffective for unapproved indication,6,16698933
0,22.0,Off label use,6,16699065
1,22.0,Expired product administered,6,16699065
2,22.0,Fatigue,6,16699065
0,22.0,Bladder neoplasm,1,16699214
0,22.0,Polyneuropathy,3,16699228
0,22.0,Metastases to lung,4,16699249
1,22.0,Granulocyte count decreased,4,16699249
2,22.0,Body temperature increased,4,16699249
3,22.0,Thrombocytopenia,4,16699249
4,22.0,Febrile neutropenia,4,16699249
5,22.0,Neutropenia,4,16699249
6,22.0,Germ cell cancer,4,16699249
7,22.0,Anaemia,4,16699249
0,22.0,Neutropenia,1,16699278
1,22.0,White blood cell count decreased,3,16699278
2,22.0,Pain,3,16699278
0,22.0,Renal impairment,2,16699346
1,22.0,Blood creatinine increased,1,16699346
2,22.0,Nephropathy toxic,6,16699346
3,22.0,Lymphangioma,6,16699346
4,22.0,Malignant neoplasm progression,6,16699346
0,22.1,Immobile,1,16699376
1,22.1,Nausea,1,16699376
2,22.1,Sleep disorder,1,16699376
3,22.1,Dizziness,1,16699376
4,22.1,Tobacco abuse,1,16699376
5,22.1,Diarrhoea,1,16699376
6,22.1,Rash,1,16699376
7,22.1,Malaise,2,16699376
8,22.1,Decreased appetite,1,16699376
0,22.0,Blood pressure increased,3,16699531
1,22.0,Dry mouth,3,16699531
2,22.0,Constipation,3,16699531
3,22.0,Decreased appetite,3,16699531
4,22.0,Product use in unapproved indication,1,16699531
5,22.0,Rash pruritic,1,16699531
6,22.0,Nausea,1,16699531
7,22.0,Dysgeusia,3,16699531
8,22.0,Dyspnoea,3,16699531
9,22.0,Abdominal pain upper,1,16699531
10,22.0,Vomiting,3,16699531
0,22.0,Dysstasia,3,16699581
1,22.0,Depression,6,16699581
2,22.0,Dehydration,1,16699581
3,22.0,Nausea,3,16699581
4,22.0,Diarrhoea,3,16699581
5,22.0,Vomiting,3,16699581
6,22.0,Feeling abnormal,6,16699581
7,22.0,Fatigue,3,16699581
8,22.0,Decreased appetite,3,16699581
9,22.0,Dyspnoea,3,16699581
10,22.0,Malaise,3,16699581
11,22.0,Abdominal distension,6,16699581
0,22.0,Death,5,16699604
0,22.0,Proctalgia,4,16699648
1,22.0,Clostridium difficile colitis,1,16699648
0,22.0,Acute myeloid leukaemia,3,16699666
0,22.0,Tachycardia,1,16699680
1,22.0,Tremor,1,16699680
2,22.0,Back pain,1,16699680
3,22.0,Dyspnoea,1,16699680
0,22.0,Metastases to bone,6,16699684
1,22.0,Metastases to liver,6,16699684
2,22.0,Pleural effusion,6,16699684
3,22.0,Invasive ductal breast carcinoma,6,16699684
4,22.0,Malignant neoplasm progression,6,16699684
5,22.0,Breast cancer,6,16699684
0,22.0,Ocular hyperaemia,1,16699688
1,22.0,Dizziness,1,16699688
2,22.0,Heart rate increased,1,16699688
3,22.0,Vomiting,1,16699688
0,22.0,Ischaemic stroke,4,16699690
1,22.0,Cardiac failure,3,16699690
0,22.0,Evans syndrome,1,16699691
1,22.0,Type II hypersensitivity,1,16699691
2,22.0,Acute kidney injury,1,16699691
0,22.0,Hyperhidrosis,2,16699795
1,22.0,Body temperature increased,2,16699795
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,16699796
1,22.1,Stomatitis,1,16699796
0,22.1,Cardiac arrest,5,16699852
0,22.0,Drug eruption,1,16699893
0,22.0,Death,5,16699910
0,22.0,Erythema,6,16699947
1,22.0,Rash vesicular,6,16699947
2,22.0,Eye haematoma,6,16699947
0,22.0,Liver disorder,3,16699951
1,22.0,Rash,2,16699951
0,22.0,Nasopharyngitis,6,16700025
1,22.0,Prostate cancer metastatic,6,16700025
0,22.0,Cardiac dysfunction,6,16700037
0,22.0,Thrombocytopenia,2,16700054
0,22.0,Carbohydrate antigen 125 increased,6,16700058
0,22.0,Product use in unapproved indication,6,16700104
1,22.0,Fatigue,6,16700104
0,22.0,Thrombocytopenia,3,16700106
1,22.0,Anaemia,3,16700106
2,22.0,Leukopenia,3,16700106
0,22.0,Pulmonary fibrosis,2,16700127
0,22.0,Death,5,16700172
1,22.0,Pyrexia,3,16700172
0,22.0,Pleural effusion,2,16700236
1,22.0,Cardiomyopathy,5,16700236
2,22.0,Malaise,6,16700236
0,22.0,Paraesthesia,1,16700245
0,22.0,Oncologic complication,2,16700251
0,22.0,Streptococcal bacteraemia,2,16700252
0,22.0,Neuropathy peripheral,6,16700278
0,22.0,B-cell lymphoma,6,16700347
0,22.0,Periorbital disorder,2,16700358
1,22.0,Dermatitis,2,16700358
2,22.0,Lacrimation increased,1,16700358
0,22.1,Death,5,16700364
0,22.0,Metastasis,2,16700370
0,22.0,Stevens-Johnson syndrome,2,16700371
0,22.0,Abdominal pain,3,16700405
0,22.0,Diarrhoea haemorrhagic,6,16700409
0,22.0,Gastric perforation,1,16700418
1,22.0,Peritonitis,1,16700418
0,22.1,Lung disorder,5,16700419
1,22.1,Pemphigoid,2,16700419
2,22.1,Overdose,6,16700419
3,22.1,Pneumothorax,5,16700419
4,22.1,Malignant neoplasm progression,5,16700419
0,22.0,Malignant fibrous histiocytoma,5,16700450
1,22.0,Liver disorder,6,16700450
2,22.0,Somnolence,6,16700450
0,22.1,Asthenia,3,16700469
1,22.1,Product dose omission,6,16700469
2,22.1,Therapy cessation,6,16700469
3,22.1,Blood glucose increased,3,16700469
4,22.1,Seizure,3,16700469
0,22.0,Pancreatitis,1,16700485
0,22.0,Acute pulmonary oedema,1,16700582
1,22.0,Cardiotoxicity,1,16700582
2,22.0,Myocardial infarction,1,16700582
3,22.0,Left ventricular failure,1,16700582
4,22.0,Cardiogenic shock,1,16700582
0,22.0,Cerebral infarction,6,16700584
0,22.0,Thrombosis,1,16700601
0,22.0,Herpes zoster,6,16700624
0,22.0,Gastroenteritis radiation,2,16700672
1,22.0,Skin laceration,6,16700672
2,22.0,Hand fracture,6,16700672
3,22.0,Jaundice,6,16700672
4,22.0,Bone marrow failure,6,16700672
5,22.0,Ocular icterus,6,16700672
6,22.0,Stress ulcer,2,16700672
0,22.0,Palliative care,3,16700700
0,22.0,Abdominal adhesions,2,16700705
1,22.0,Malaise,6,16700705
2,22.0,Vomiting,2,16700705
3,22.0,Weight decreased,6,16700705
4,22.0,Renal failure,5,16700705
5,22.0,Abdominal pain upper,2,16700705
0,22.0,Endothelial dysfunction,6,16700739
1,22.0,Ileus,6,16700739
2,22.0,Renal cyst,6,16700739
0,22.0,Febrile bone marrow aplasia,1,16700749
0,22.1,Cardiotoxicity,6,16700766
0,22.0,Posterior reversible encephalopathy syndrome,1,16700773
0,22.0,Interstitial lung disease,6,16700799
0,22.0,Haemodynamic instability,5,16700817
1,22.0,Neutropenic sepsis,5,16700817
2,22.0,Metabolic acidosis,5,16700817
3,22.0,Hypokalaemia,5,16700817
0,22.0,Coagulopathy,3,16700845
1,22.0,Hepatic function abnormal,5,16700845
2,22.0,Platelet count decreased,3,16700845
3,22.0,Renal impairment,5,16700845
4,22.0,General physical health deterioration,3,16700845
5,22.0,Malaise,3,16700845
6,22.0,Disseminated intravascular coagulation,5,16700845
7,22.0,Malignant neoplasm progression,5,16700845
8,22.0,Anaemia,3,16700845
0,22.0,Asthenia,6,16700855
1,22.0,Gait inability,6,16700855
0,22.1,Interstitial lung disease,5,16700887
0,22.0,Nausea,6,16700890
1,22.0,Fatigue,6,16700890
2,22.0,Peripheral sensory neuropathy,6,16700890
3,22.0,Decreased appetite,6,16700890
4,22.0,Malaise,6,16700890
5,22.0,Hypersensitivity,6,16700890
6,22.0,Vomiting,6,16700890
0,22.1,Pericardial effusion,1,16700895
0,22.1,Squamous cell carcinoma,1,16700909
1,22.1,Basal cell carcinoma,1,16700909
0,22.0,Angle closure glaucoma,6,16701017
1,22.0,Hallucination,6,16701017
2,22.0,Disorientation,6,16701017
3,22.0,Faecaloma,1,16701017
4,22.0,Vitamin B12 increased,6,16701017
5,22.0,Dysgraphia,6,16701017
6,22.0,Constipation,1,16701017
7,22.0,"Delusional disorder, persecutory type",6,16701017
8,22.0,Confusional state,6,16701017
9,22.0,Prostate cancer metastatic,6,16701017
10,22.0,"Hallucination, visual",6,16701017
11,22.0,Affect lability,6,16701017
0,22.0,Rash,6,16701018
1,22.0,Pyrexia,6,16701018
2,22.0,Vomiting,6,16701018
3,22.0,Dry mouth,6,16701018
4,22.0,Nausea,6,16701018
5,22.0,Fatigue,6,16701018
0,22.0,Drug ineffective,6,16701047
1,22.0,Disease progression,5,16701047
0,22.0,Pyrexia,2,16701059
1,22.0,Chills,2,16701059
0,22.0,Radiation pneumonitis,6,16701067
0,22.0,Neuropathy peripheral,1,16701072
1,22.0,Neutropenia,4,16701072
2,22.0,Hypertension,4,16701072
3,22.0,Proteinuria,1,16701072
4,22.0,Rash,6,16701072
0,22.0,Sepsis,2,16701107
1,22.0,Cellulitis,2,16701107
2,22.0,Localised infection,2,16701107
0,22.0,Diabetic ketoacidosis,3,16701108
1,22.0,Type 1 diabetes mellitus,3,16701108
2,22.0,Acute kidney injury,6,16701108
0,22.0,Hypercalcaemia,1,16701119
1,22.0,Acute kidney injury,1,16701119
0,22.0,Death,5,16701144
0,22.1,Aspartate aminotransferase increased,6,16701145
1,22.1,Red cell distribution width increased,6,16701145
2,22.1,Glomerular filtration rate decreased,6,16701145
3,22.1,Alanine aminotransferase increased,6,16701145
4,22.1,Leukopenia,3,16701145
5,22.1,Gamma-glutamyltransferase increased,6,16701145
6,22.1,Deep vein thrombosis,1,16701145
0,22.0,Seizure,6,16701146
1,22.0,Weight decreased,6,16701146
0,22.1,Blood creatinine increased,6,16701147
1,22.1,Transaminases increased,3,16701147
2,22.1,C-reactive protein increased,6,16701147
0,22.0,Terminal state,6,16701166
1,22.0,Device defective,6,16701166
2,22.0,Product leakage,6,16701166
3,22.0,Intercepted medication error,6,16701166
4,22.0,Feeling abnormal,6,16701166
0,22.1,Nausea,3,16701172
1,22.1,Dehydration,6,16701172
2,22.1,Fatigue,3,16701172
3,22.1,Loss of consciousness,6,16701172
4,22.1,Abdominal discomfort,3,16701172
0,22.0,Blood thyroid stimulating hormone increased,6,16701178
1,22.0,Rash,1,16701178
0,22.0,Pruritus generalised,2,16701185
1,22.0,Eye pruritus,2,16701185
2,22.0,Inappropriate schedule of product administration,6,16701185
3,22.0,Bone loss,6,16701185
4,22.0,Asthenia,6,16701185
0,22.0,Muscle haemorrhage,5,16701401
1,22.0,Coronary artery disease,6,16701401
2,22.0,Vitiligo,6,16701401
3,22.0,Immune-mediated adverse reaction,3,16701401
4,22.0,Ventricular hypokinesia,6,16701401
5,22.0,Ascites,6,16701401
6,22.0,Myositis,3,16701401
7,22.0,Cardiomyopathy,3,16701401
8,22.0,Hepatitis,2,16701401
9,22.0,Malignant neoplasm progression,6,16701401
10,22.0,Myopathy,3,16701401
11,22.0,Rash generalised,6,16701401
0,22.0,Dermatitis,1,16701415
1,22.0,Lacrimation increased,1,16701415
2,22.0,Periorbital disorder,2,16701415
0,22.1,Hospitalisation,6,16701425
1,22.1,Chondrocalcinosis pyrophosphate,3,16701425
2,22.1,Staphylococcal infection,6,16701425
3,22.1,Nausea,3,16701425
4,22.1,Knee operation,6,16701425
0,22.0,Toxicity to various agents,5,16701489
1,22.0,Drug interaction,5,16701489
0,22.0,Feeling of despair,6,16701527
1,22.0,Death,5,16701527
0,22.1,Diarrhoea,6,16701563
1,22.1,Colitis,6,16701563
2,22.1,Neutropenia,6,16701563
3,22.1,Neuropathy peripheral,6,16701563
0,22.1,Lower respiratory tract infection,6,16701564
1,22.1,Death,5,16701564
2,22.1,Pleural effusion,2,16701564
3,22.1,Pneumonia,1,16701564
0,22.0,Radiation pneumonitis,6,16701565
